Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -13.94% is 27% above its 5-year average of -18.99%, around the middle of its 5-year range (-49.02%–2.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.05% below its 12-month average of -13.40%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -13.94%.
RETURN ON INVESTED CAPITAL (ROIC)
-13.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-13.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-25.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-18.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-5.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.05%
CURRENT VS 3Y AVG
+45.97%
CURRENT VS 5Y AVG
+26.57%
CURRENT VS 10Y AVG
-157.60%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+60.88%
vs the sector median at left
Inogen, Inc.
Market Cap
$156.63M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-13.40%
3Y Avg
-25.81%
5Y Avg
-18.99%
Market Cap
$154.34M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-138.87%
3Y Avg
-97.17%
5Y Avg
-81.85%
Market Cap
$159.22M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$159.44M
Return on Invested Capital (ROIC)
-57.59%
TTM Avg
-65.44%
3Y Avg
-58.20%
5Y Avg
-45.38%
Market Cap
$160.65M
Return on Invested Capital (ROIC)
-38.56%
TTM Avg
-39.74%
3Y Avg
-42.41%
5Y Avg
-37.88%
Market Cap
$153.44M
Return on Invested Capital (ROIC)
-22.15%
TTM Avg
-29.24%
3Y Avg
-31.64%
5Y Avg
-30.48%
Market Cap
$151.58M
Return on Invested Capital (ROIC)
-165.56%
TTM Avg
-176.54%
3Y Avg
-127.81%
5Y Avg
-112.12%
Market Cap
$162.23M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$162.28M
Return on Invested Capital (ROIC)
-49.08%
TTM Avg
-23.18%
3Y Avg
-21.02%
5Y Avg
-18.22%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inogen, Inc. (INGN) | $156.63M | -13.94% | -13.40% | -25.81% | -18.99% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $154.34M | N/A | -138.87% | -97.17% | -81.85% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -143.97% | -52.39% | -55.03% | -91.26% |
| PepGen Inc. (PEPG)vs › | $159.44M | -57.59% | -65.44% | -58.20% | -45.38% |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.65M | -38.56% | -39.74% | -42.41% | -37.88% |
| Neuronetics, Inc. (STIM)vs › | $153.44M | -22.15% | -29.24% | -31.64% | -30.48% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | -165.56% | -176.54% | -127.81% | -112.12% |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | -135.38% | -110.80% | -91.23% | -65.73% |
| Quanterix Corporation (QTRX)vs › | $162.28M | -49.08% | -23.18% | -21.02% | -18.22% |
| Veraxa Biotech Holding AG (VRXA)vs › | $149.89M | N/A | N/A | N/A | N/A |
ROIC
-13.9%
ROE
-14.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -13.94% |
| 2026-03-31 | -13.59% |
| 2025-12-31 | -12.85% |
| 2025-09-30 | -13.17% |
| 2025-06-30 | -13.46% |
| 2025-03-31 | -13.95% |
| 2024-12-31 | -19.37% |
| 2024-09-30 | -25.71% |
| 2024-06-30 | -41.84% |
| 2024-03-31 | -42.92% |
| 2023-12-31 | -43.12% |
| 2023-09-30 | -49.02% |
| 2023-06-30 | -32.53% |
| 2023-03-31 | -29.03% |
| 2022-12-31 | -25.09% |
| 2022-09-30 | -8.28% |
| 2022-06-30 | -4.08% |
| 2022-03-31 | -0.53% |
| 2021-12-31 | 1.19% |
| 2021-09-30 | 2.29% |
| 2021-06-30 | 0.26% |
| 2021-03-31 | -2.85% |
| 2020-12-31 | -2.97% |
| 2020-09-30 | -2.90% |
| 2020-06-30 | -0.43% |
| 2020-03-31 | 2.69% |
| 2019-12-31 | 4.30% |
| 2019-09-30 | 7.14% |
| 2019-06-30 | 9.00% |
| 2019-03-31 | 9.89% |
| 2018-12-31 | 11.51% |
| 2018-09-30 | 12.32% |
| 2018-06-30 | 10.74% |
| 2018-03-31 | 9.04% |
| 2017-12-31 | 8.10% |
| 2017-09-30 | 11.03% |
| 2017-06-30 | 10.22% |
| 2017-03-31 | 9.76% |
| 2016-12-31 | 8.54% |
| 2016-09-30 | 8.98% |
| 2016-06-30 | 9.10% |
| 2016-03-31 | 8.62% |
| 2015-12-31 | 8.48% |
| 2015-09-30 | 6.99% |
| 2015-06-30 | 6.72% |
| 2015-03-31 | 6.20% |
| 2014-12-31 | 5.87% |
| 2014-09-30 | 8.24% |
| 2014-06-30 | 5.51% |
| 2014-03-31 | 4.54% |
| 2013-12-31 | 6.57% |
| 2013-09-30 | 8.41% |
| 2013-06-30 | 8.24% |
